SFC Capital

Chiron offers a revolutionary approach to managing chronic illnesses. Based on the user's profile, it uses AI to suggest tailored self-care treatments that have the highest chance of success. It then offers a straightforward framework for evaluating the results.

LaennecAI is a clinical AI company specializing in chronic disease management solutions. It has developed a medical device, a digital stethoscope, which transforms modern smartphones into powerful diagnostic tools. The company's technology enables precise monitoring and analysis of respiratory and cardiac sounds, facilitating telemedicine, remote patient monitoring, and virtual wards. This ensures patients receive in-depth, reliable analysis and continuous care.

Reneural develops innovative, accessible technologies focused on improving cardiovascular disease treatment and management. Their flagship product is a wearable smart medical system designed to prevent blood clots in lower limbs, usable both clinically and at home.

Llusern Scientific operates molecular point-of-care testing centers, focusing on urinary tract infection diagnostics. Their innovative technology rapidly detects and identifies bacteria, empowering medical professionals to make prompt decisions and enhance patient care.

4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Vesynta is a medical technology company that specializes in individualizing drug therapy through its innovative blood monitoring platform. The company’s technology integrates drug monitoring hardware with precision dosing software to create a universal bedside platform aimed at evidence-based clinical decision support. By utilizing robotic automation, analytical software, and machine learning, Vesynta's system determines a patient's drug exposure, empowering healthcare providers to make data-driven decisions. This approach facilitates the personalization of drug dosages, ultimately enhancing treatment outcomes while minimizing side effects for patients.

Medwise.ai operates a customizable search platform that uses natural language processing and artificial intelligence technologies to provide clinical decision support for doctors. Its real-world data offers insights to various healthcare stakeholders, enabling doctors to organize medical knowledge and enhance patient care outcomes.

4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

NIQS Technology is a spin-out from the University of Leeds specializing in innovative quantum glucose management solutions aimed at transforming diabetes care. The company has developed a patented, non-invasive glucose monitoring technology that employs a contact-based wearable device made of nano-engineered glass. This device mimics the optical properties of glucose, allowing for continuous, accurate glucose level monitoring without the need for needles or blood sampling. By providing accessible and user-friendly monitoring solutions, NIQS Technology seeks to empower individuals living with diabetes to manage their condition more effectively and improve their overall quality of life, while minimizing the risk of complications associated with traditional glucose management methods.

Llusern Scientific operates molecular point-of-care testing centers, focusing on urinary tract infection diagnostics. Their innovative technology rapidly detects and identifies bacteria, empowering medical professionals to make prompt decisions and enhance patient care.

PulmoBioMed is a company focused on providing innovative solutions for clinicians and researchers through non-invasive sampling of fluids. The firm has developed a passive fluid aerosol sampler designed to capture exhaled breath condensate and aerosol samples. This product effectively segregates exhaled and environmental particles by size, addressing critical challenges such as sample contamination and loss. PulmoBioMed's technology aims to generate highly reproducible data with precise digital molecular analysis, facilitating the study of biological agents and supporting metabolomic profiling. Through its advancements, the company seeks to enhance research capabilities and improve patient outcomes in the field of respiratory health.

Biovit is a company that specializes in the development of fortified foods. It uses 100% organic plant extracts, naturally rich in vitamins and minerals, to enhance the nutritional value of its products. The company aims to address health and environmental issues such as obesity and malnutrition, while also reducing food waste. Biovit has clinically developed and tested organic micronutrient blends for use in various food and beverage products, as well as supplements, providing consumers with organically sourced, nutrient-dense options.

Strolll is a digital health company focused on improving mobility for people with neurological disorders. It develops a B2B digital therapeutics platform that delivers clinically validated rehabilitation software on off-the-shelf augmented reality glasses. The platform supports both in-clinic (synchronous) and at-home (asynchronous) therapy, enabling rehabilitation clinics to scale services, improve access, and reduce the cost of neurorehabilitation. By personalizing therapy, the solution aims to increase patient adherence and outcomes while streamlining administrative processes and delivering meaningful data to clinics.

Decently is a company focused on developing advanced digital products aimed at improving lives through innovation. It operates a behavioral risk management platform designed to enhance the understanding of challenging patient behaviors. The platform includes features such as a quick observations module that monitors daily changes in behavior, mood, and patient activity. Additionally, it employs analytics to identify early signs of escalation and incorporates artificial intelligence to predict future incidents. This enables clinicians to make faster, evidence-based care decisions while also improving organizational efficiency.

Elaitra develops AI-driven breast cancer diagnostic tools. Their platform includes a voice-based patient engagement system powered by Generative LLM and an AI reading tool for 3D X-rays, approved by FDA and UK regulators.

MedQ is a smart platform that helps healthcare professionals complete assessments using a three-step process: Select-Send-Analyse. It is designed for clinics to transition from paper assessments to remote patient monitoring.

Medwise.ai operates a customizable search platform that uses natural language processing and artificial intelligence technologies to provide clinical decision support for doctors. Its real-world data offers insights to various healthcare stakeholders, enabling doctors to organize medical knowledge and enhance patient care outcomes.

NIQS Technology is a spin-out from the University of Leeds specializing in innovative quantum glucose management solutions aimed at transforming diabetes care. The company has developed a patented, non-invasive glucose monitoring technology that employs a contact-based wearable device made of nano-engineered glass. This device mimics the optical properties of glucose, allowing for continuous, accurate glucose level monitoring without the need for needles or blood sampling. By providing accessible and user-friendly monitoring solutions, NIQS Technology seeks to empower individuals living with diabetes to manage their condition more effectively and improve their overall quality of life, while minimizing the risk of complications associated with traditional glucose management methods.

Founded by specialists in nanotechnology, medicinal chemistry, and artificial intelligence, Nanovery aims to enable early detection of cancer through a rapid and affordable blood test. Its core technology involves AI-powered nanorobots that capture circulating tumor DNA and emit a fluorescent signal for point-of-care detection.

Hormona is a health technology company focused on enhancing women's hormonal health through innovative home testing solutions and artificial intelligence. The company offers a unique platform that allows women to measure, track, and gain insights into their hormone levels from the convenience of home. Hormona's tests are designed to be safe, accurate, and pain-free, and they work in conjunction with the Hormona app, creating a comprehensive tool for regular hormone monitoring. Supported by a team of leading endocrinologists, gynecologists, and nutritionists, Hormona aims to empower women to understand and manage their hormonal health, promoting overall well-being.

Strolll is a digital health company focused on improving mobility for people with neurological disorders. It develops a B2B digital therapeutics platform that delivers clinically validated rehabilitation software on off-the-shelf augmented reality glasses. The platform supports both in-clinic (synchronous) and at-home (asynchronous) therapy, enabling rehabilitation clinics to scale services, improve access, and reduce the cost of neurorehabilitation. By personalizing therapy, the solution aims to increase patient adherence and outcomes while streamlining administrative processes and delivering meaningful data to clinics.

BBL Protect specializes in the development of medical devices and solutions aimed at enhancing the safe transportation of patients with infectious diseases or contaminants. The company focuses on creating patient transfer systems that prioritize infection control, ensuring the protection of patients, healthcare staff, and the surrounding environment. By delivering innovative products that emphasize safety and functionality, BBL Protect enables healthcare service providers to achieve higher standards in infection control within hospitals and emergency vehicles, thereby improving overall safety and practicality in patient transfer scenarios.

Hormona is a health technology company focused on enhancing women's hormonal health through innovative home testing solutions and artificial intelligence. The company offers a unique platform that allows women to measure, track, and gain insights into their hormone levels from the convenience of home. Hormona's tests are designed to be safe, accurate, and pain-free, and they work in conjunction with the Hormona app, creating a comprehensive tool for regular hormone monitoring. Supported by a team of leading endocrinologists, gynecologists, and nutritionists, Hormona aims to empower women to understand and manage their hormonal health, promoting overall well-being.

Elaitra develops AI-driven breast cancer diagnostic tools. Their platform includes a voice-based patient engagement system powered by Generative LLM and an AI reading tool for 3D X-rays, approved by FDA and UK regulators.

Strolll is a digital health company focused on improving mobility for people with neurological disorders. It develops a B2B digital therapeutics platform that delivers clinically validated rehabilitation software on off-the-shelf augmented reality glasses. The platform supports both in-clinic (synchronous) and at-home (asynchronous) therapy, enabling rehabilitation clinics to scale services, improve access, and reduce the cost of neurorehabilitation. By personalizing therapy, the solution aims to increase patient adherence and outcomes while streamlining administrative processes and delivering meaningful data to clinics.

4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Founded by specialists in nanotechnology, medicinal chemistry, and artificial intelligence, Nanovery aims to enable early detection of cancer through a rapid and affordable blood test. Its core technology involves AI-powered nanorobots that capture circulating tumor DNA and emit a fluorescent signal for point-of-care detection.

Medwise.ai operates a customizable search platform that uses natural language processing and artificial intelligence technologies to provide clinical decision support for doctors. Its real-world data offers insights to various healthcare stakeholders, enabling doctors to organize medical knowledge and enhance patient care outcomes.

4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

CircaGene Ltd is a London-based company that specializes in bioinformatics and genetic testing services. Established in 2018, it offers a direct-to-consumer platform where individuals can order personal DNA tests while ensuring privacy through patented end-to-end encryption. The company provides actionable insights from DNA analysis to help users identify hereditary health risks, improve their lifestyle, and make informed health decisions. CircaGene's platform features user-friendly reports and connects consumers with advanced genetic research algorithms, facilitating access to comprehensive healthcare resources. By prioritizing genetic privacy and security, CircaGene aims to empower individuals to take proactive measures in managing their health and well-being.

Medtech

Algocyte is a UK-based company that specializes in providing comprehensive, medically-driven solutions for remote blood testing and health monitoring. The company enables healthcare professionals to remotely track and assess patients with various conditions, including cancer, anemia, and autoimmune disorders. Algocyte's innovative medical device conducts a wide range of hematological and biochemical tests, allowing for continuous health monitoring. By analyzing collected data over time, Algocyte generates detailed health profiles that offer a more accurate understanding of an individual's health status compared to traditional single-snapshot assessments.

Whiterabbit.ai specializes in creating artificial intelligence-driven software designed to enhance the early detection and diagnosis of breast cancer. The company's platform aims to transform the cancer screening process by addressing key challenges, including patient compliance and provider accuracy. By leveraging advanced technology, Whiterabbit.ai seeks to improve patient engagement and overall care quality, ultimately enhancing outcomes in cancer diagnosis and treatment.

Intoolab LTD, founded in 2016 and headquartered in London, specializes in developing an artificial intelligence platform known as Tzager. Tzager is a pioneering framework for Bayesian Inference, particularly designed for biomedical research, drug discovery, and personalized medicine. It distinguishes itself from conventional deep learning algorithms by utilizing a unique framework based on Causal Equations and Bayesian Networks. The platform enables researchers, R&D professionals, academics, and students to navigate complex research projects by offering features such as biochemical analysis, predictor research/models, and literature intelligence. By emulating human reasoning in understanding biomedicine, Tzager enhances the ability to simulate pathways and provide actionable insights, thereby facilitating collaboration across various scientific fields.

ORB Innovations is a deep tech digital health platform focused on providing high-quality biometric data and insights. The company has developed a smart mouthguard device that monitors head movements to prevent misdiagnosed injuries in sports. Utilizing advanced wearable technology, including accelerometers, gyroscopes, and magnetometers, the device tracks the forces experienced by athletes, offering detailed reports that enable users to monitor their performance and well-being. Through this innovative approach, ORB Innovations aims to empower individuals to lead healthier, happier lives by facilitating next-generation access to critical performance and health data.

Jupiter Diagnostics is a company that specializes in innovative blood testing solutions utilizing patented nano crystal labeled technology. This technology allows for the rapid processing of multiple blood tests from a simple finger prick, delivering results within 10 minutes and at a cost significantly lower than traditional laboratory testing. By providing high-quality and affordable diagnostics, Jupiter Diagnostics aims to enhance the accessibility of medical testing for both clinicians and patients. Their intuitive testing process simplifies blood sample collection, facilitating quicker decision-making for healthcare practitioners and ultimately improving patient care.

Numeration Systems Ltd is a company based in Truro, United Kingdom, that specializes in developing granular health and wellbeing operational models and a suite of web-based tools. Founded in 2013, the company focuses on critical aspects of healthcare service management, including service repatriation, demand and capacity planning, and carbon footprint modeling. Additionally, Numeration Systems offers benchmarking and integrated care solutions aimed at redesigning healthcare services. The company also provides consultancy services to help organizations implement its operational models effectively.

Rocking the tea world with a range of vitamin enriched super green teas.

Numeration Systems Ltd is a company based in Truro, United Kingdom, that specializes in developing granular health and wellbeing operational models and a suite of web-based tools. Founded in 2013, the company focuses on critical aspects of healthcare service management, including service repatriation, demand and capacity planning, and carbon footprint modeling. Additionally, Numeration Systems offers benchmarking and integrated care solutions aimed at redesigning healthcare services. The company also provides consultancy services to help organizations implement its operational models effectively.

FindMe Health is an online platform designed to empower patients by providing access to reliable and comparable information on the quality and pricing of healthcare services. Targeting individuals who are seeking alternatives to NHS treatment, especially when they are ineligible or facing long waiting times, the platform allows users to compare hospital consultants based on various criteria such as procedure volume, patient feedback, hospital location, and treatment costs. This comprehensive comparison helps patients make informed decisions regarding their healthcare options. In addition to offering detailed insights on conditions, hospitals, and consultants, FindMe Health facilitates the booking of initial consultations directly through the site. By consolidating essential information in one place, it aims to simplify the often confusing landscape of self-pay healthcare and enable patients to take control of their health decisions.

Performr.ai is a Biotechnology Research firm offering monitoring and body sensors for personalised health and insights.

Biovit is a company that specializes in the development of fortified foods. It uses 100% organic plant extracts, naturally rich in vitamins and minerals, to enhance the nutritional value of its products. The company aims to address health and environmental issues such as obesity and malnutrition, while also reducing food waste. Biovit has clinically developed and tested organic micronutrient blends for use in various food and beverage products, as well as supplements, providing consumers with organically sourced, nutrient-dense options.

Ambient Works is an IoT company that develops air quality trackers and monitoring devices for workplaces. Its devices provide real-time sensing of particulate matter, CO2, VOCs, NOx, temperature and humidity, and are operated via an app built with AI. The platform supports historical data tracking, insights, data sharing, and goal setting, with integrations to third-party dashboards and automation tools, enabling workspaces and workshops to monitor air quality and promote healthier environments.

Eupnoos is a health-tech company specializing in digital lung health solutions. It offers smartphone-based, automated lung function testing and data interpretation for various devices and telehealth platforms.